Work-Anxiety and Sickness Absence After a Short Inpatient Cognitive Behavioral Group Intervention in Comparison to a Recreational Group Meeting
Overview
Affiliations
Objective: The aim of this study was to study the effects of a short-term cognitive behavior therapy on work-anxiety and sickness-absence in patients with work-anxiety.
Methods: Three-hundred forty-five inpatients who suffered from cardiologic, neurological, or orthopedic problems and additionally work-anxiety were randomly assigned into two different group interventions. Patients got four sessions of a group intervention, which either focused on cognitive behavior-therapy anxiety-management (work-anxiety coping group, WAG) or unspecific recreational activities (RG).
Results: No differences were found between WAG and RG for work-anxiety and subjective work ability. When looking at patients who were suffering only from work-anxiety, and no additional mental disorder, the duration of sickness absence until 6 months follow-up was shorter in the WAG (WAG: 11 weeks, RG: 16 weeks, P = 0.050).
Conclusion: A short-term WAG may help return to work in patients with work-anxieties, as long as there is no comorbid mental disorder.
Who Panics When They Think of Work?.
Muschalla B Int J Environ Res Public Health. 2025; 22(2).
PMID: 40003386 PMC: 11855894. DOI: 10.3390/ijerph22020160.
[Incapacity to work due to mental disorders-economic, individual, and treatment-specific aspects].
Melzner L, Kroger C Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024; 67(7):751-759.
PMID: 38789543 PMC: 11230963. DOI: 10.1007/s00103-024-03894-6.
Nowrouzi-Kia B, Garrido P, Gohar B, Yazdani A, Chattu V, Bani-Fatemi A Healthcare (Basel). 2023; 11(10).
PMID: 37239689 PMC: 10217842. DOI: 10.3390/healthcare11101403.
Evaluation of a Group Therapy for Work-Related Mental Disorders.
Hondong S, Morawa E, Kastel-Hoffmann S, Kandler A, Erim Y Int J Environ Res Public Health. 2023; 20(3).
PMID: 36768039 PMC: 9915433. DOI: 10.3390/ijerph20032673.
Pausch K, Blanke K, Niederberger V, Egli S, Rufer M, Ajdacic-Gross V Neuropsychiatr. 2022; 36(3):104-115.
PMID: 35428933 PMC: 9012433. DOI: 10.1007/s40211-022-00415-2.